IndiaMTF — home
Stock

Gland Pharma — MTF Book

GLAND · Gland Pharma Limited
Health Technology

Daily Margin Trading Facility book for Gland Pharma across NSE and BSE, from 01 Dec 2020. All figures in ₹ crore, derived from exchange public disclosures.

What is Gland Pharma’s MTF book?

Gland Pharma Limited (GLAND) has ₹72 crore funded under Margin Trading Facility across NSE and BSE as of 23 Oct 2026 — 0.05% of India’s MTF book, ranking #483. Over 1M (the last 30 trading days) the funded value has fallen 65.4%, with the number of shares under margin down 64.1%.

Funded value
₹72 Cr
as of 23 Oct 2026
Rank in book
#483
1,401 days tracked
Share of book
0.05%
of the whole NSE + BSE book
Peak funded
₹208 Cr
on 08 Sep 2026
Largest single-day addition
+₹95 Cr
on 04 Sep 2026
Largest single-day unwind
−₹19 Cr
on 15 Sep 2026
Free-float market cap
₹25,305 Cr
full market cap ₹46,645 Cr · 54.2% free float · Mid cap
MTF share of free float
0.30%
0.7× the median mid cap · 0.4× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.06%0.26%0.45%0.65%Feb 2024Oct 2026
View as table: share of free float on margin33 months
Month-end% of free float
23 Oct 20260.301%
30 Sep 20260.553%
31 Aug 20260.552%
31 Jul 20260.582%
30 Jun 20260.502%
29 May 20260.233%
30 Apr 20260.126%
30 Mar 20260.159%
27 Feb 20260.172%
30 Jan 20260.202%
31 Dec 20250.231%
28 Nov 20250.235%
31 Oct 20250.208%
30 Sep 20250.222%
29 Aug 20250.263%
31 Jul 20250.277%
30 Jun 20250.160%
30 May 20250.258%
30 Apr 20250.356%
28 Mar 20250.174%
28 Feb 20250.207%
31 Jan 20250.268%
31 Dec 20240.256%
29 Nov 20240.249%
31 Oct 20240.283%
30 Sep 20240.275%
30 Aug 20240.234%
30 Jul 2024†0.254%
28 Jun 20240.263%
31 May 20240.312%
30 Apr 20240.443%
28 Mar 20240.204%
29 Feb 20240.237%

† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).

Dated events

NSE & BSE split

How GLAND’s funded book divides across the two exchanges, as of 23 Oct 2026.
NSE
NSE ₹69 Cr · 96.2%BSE ₹3 Cr · 3.8%

MTF vs Price

Margin-funded outstanding for GLAND in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹2,826.80
as of 23 Oct 2026
Price, 1M
−6.6%
adjusted for splits and bonuses
Delivery, 20-day avg
54.5%
of traded volume actually settled
Sessions to unwind
1
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D−₹7−9.2%−9.4%
−28,081
−0.8%unwinding as it falls
10D−₹29−28.6%−28.0%
−1,04,677
−8.2%unwinding as it falls
1M−₹136−65.4%−64.1%
−4,81,714
−4.5%unwinding as it falls
3M−₹27−27.1%−35.3%
−1,46,982
+18.9%unwinding into strength
6M+₹55+318.6%+189.8%
+1,76,569
+57.4%building into strength
1Y+₹40+125.0%+64.9%
+1,06,090
+46.3%building into strength

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where GLAND has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

GLAND — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
23 Oct 202672−₹70.05%483
22 Oct 202679−₹10.05%465
21 Oct 202680−₹100.05%463
19 Oct 202691−₹60.06%421
16 Oct 202697−₹00.06%398
15 Oct 202698−₹30.06%396
14 Oct 2026100+₹00.06%380
13 Oct 2026100−₹30.06%381
12 Oct 2026102+₹10.07%376
09 Oct 2026102+₹10.07%377
08 Oct 2026101−₹60.06%377
07 Oct 2026107−₹20.07%362
06 Oct 2026109−₹60.07%357
05 Oct 2026115+₹00.07%338
01 Oct 2026115−₹40.07%339
30 Sep 2026119+₹80.07%331
29 Sep 2026112−₹100.07%349
28 Sep 2026122−₹30.08%327
25 Sep 2026125−₹20.08%318
24 Sep 2026128−₹80.08%312
23 Sep 2026135−₹20.09%294
22 Sep 2026137−₹40.09%285
21 Sep 2026141−₹150.09%271
18 Sep 2026156−₹110.10%235
17 Sep 2026166−₹50.11%221
16 Sep 2026171−₹50.11%219
15 Sep 2026176−₹190.11%216
11 Sep 2026195−₹80.12%188
10 Sep 2026202+₹40.13%179
09 Sep 2026198—0.13%182

GLAND within Health Technology

Ranked #24 of 61 funded Health Technology stocks, carrying 1.1% of that sector’s margin book. Its 0.30% of free float on margin is 0.3× the sector median of 0.90%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
22SENORESSenores Pharmaceuticals₹811.2%2.58%+22.2%
23ONESOURCEOnesource Specialty Pharma₹781.2%0.62%+73.3%
24GLANDGland Pharma₹721.1%0.30%−65.4%
25ANTHEMAnthem Biosciences₹671.0%0.47%−3.3%
26SUVENSuven Life Sciences₹641.0%2.14%+1.1%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.